Itamar Medical Equity 2024

Itamar Medical Aktienanalyse

What does Itamar Medical do?

Itamar Medical Ltd is a company specialized in the development and marketing of non-invasive diagnostic and monitoring solutions for sleep disorders, heart diseases, and peripheral vascular diseases. The company was founded in Israel in 1997. The history of Itamar Medical begins with the development of the PAT system (Peripheral Arterial Tone), a device that uses the peripheral arterial tonometer to measure blood flow. With this system, doctors were able to record patients' sleep for the first time and diagnose sleep disorders such as obstructive sleep apnea syndrome (OSAS) or restless leg syndrome (RLS). Over the years, the company has expanded its offerings and developed various solutions to improve the diagnosis and monitoring of heart and vascular diseases. Itamar Medical's products now include the EndoPAT, WatchPAT, and Total Sleep Solution, among others. The EndoPAT is a non-invasive medical device that measures the endothelial function state of patients. This refers to the ability of blood vessels to dilate when needed to increase blood flow. The EndoPAT allows doctors to assess the cardiovascular health status of patients and predict the risk of cardiovascular diseases. The WatchPAT is a wearable sleep monitor that wirelessly connects to an app. The device records the sleep architecture of patients and automatically detects sleep apnea episodes, which are then displayed on the app. The WatchPAT enables doctors to improve the sleep quality of patients and diagnose sleep disorders. Itamar Medical's Total Sleep Solution offers a comprehensive solution for the management of sleep disorders. The solution includes the WatchPAT tracker, the PAT procedures for sleep disorder diagnosis, and the EndoPAT procedures for assessing cardiovascular health. This combination of technologies allows doctors to treat their patients holistically and improve their cardiovascular health and sleep quality. Itamar Medical has also formed partnerships with other companies to enhance its solutions and promote new developments. Currently, the company is collaborating with Teva Pharmaceutical Industries to develop a new formulation of Sildenafil, a medication used for treating erectile dysfunction. Overall, Itamar Medical has experienced strong growth in recent years. The company has branches in the USA, Europe, and Asia and is constantly working to expand its offerings and improve its technology for the diagnosis and monitoring of heart and sleep disorders. In summary, Itamar Medical is an innovative provider of non-invasive diagnostic and monitoring solutions for sleep disorders, heart diseases, and peripheral vascular diseases. With its wide range of products and partnerships with other companies, the company is well-positioned to continue growing and expanding in the coming years. Itamar Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Itamar Medical's Equity

Itamar Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Itamar Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Itamar Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Itamar Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Itamar Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Itamar Medical stock

What is the equity of Itamar Medical this year?

Itamar Medical has equity of 0 USD this year.

What was the equity of Itamar Medical compared to the previous year?

The equity of Itamar Medical has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Itamar Medical?

A high equity is advantageous for investors of Itamar Medical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Itamar Medical?

A low equity can be a risk for investors of Itamar Medical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Itamar Medical affect the company?

An increase in equity of Itamar Medical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Itamar Medical affect the company?

A reduction in equity of Itamar Medical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Itamar Medical?

Some factors that can affect the equity of Itamar Medical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Itamar Medical so important for investors?

The equity of Itamar Medical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Itamar Medical take to change the equity?

To change equity, Itamar Medical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Itamar Medical pay?

Over the past 12 months, Itamar Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Itamar Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Itamar Medical?

The current dividend yield of Itamar Medical is .

When does Itamar Medical pay dividends?

Itamar Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Itamar Medical?

Itamar Medical paid dividends every year for the past 0 years.

What is the dividend of Itamar Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Itamar Medical located?

Itamar Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Itamar Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Itamar Medical from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Itamar Medical pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Itamar Medical in the year 2023?

In the year 2023, Itamar Medical distributed 0 USD as dividends.

In which currency does Itamar Medical pay out the dividend?

The dividends of Itamar Medical are distributed in USD.